Alfama
Boston
About Alfama
Alfama is a pharmaceutical company that develops Carbon Monoxide-Releasing Molecules (CORMs) for therapy. The company has produced hundreds of CORMs and obtained exceptional results in various animal models of chronic and acute human diseases. CORMs have the potential to expand CO-based therapy to a wide range of high-value indications, can be administered orally or intravenously, and offer a very attractive therapeutic window and safety profile. It is based in Boston, Massachusetts.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: M&A
- Last round: Series Unknown (Dec 2005)
- Website: alfama.com.pt
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/alfama-1508321 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.